Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

Post-Withdrawl Study Confirms Vioxx, Bextra Link To Stroke Risk

Posted by Jane Akre
Thursday, August 07, 2008 3:14 PM EST
Category: Major Medical, Protecting Your Family
Tags: FDA and Prescription Drugs, Vioxx, Merck, Bextra, Cox-2 Inhibitors, Dangerous Drugs, Head Injury, Stroke, Heart Attack, NSAIDS, Celebrex, Ibuprofen, Naproxen, Indomethacin, Diclofenac

Poswithdrawl study on Vioxx and Bextra confirms link to stroke.



 IMAGE SOURCE: ©iStockphoto/ woman in pain/ author: AndreasReh


Arthritis painkiller, Vioxx was pulled from the market in 2004 after it was linked to an increase in heart attack and stroke. 

Drug maker, Merck will soon begin issuing checks from the $4.85 billion settlement it’s set aside for thousands of victims of Vioxx.  

Now a new study is adding to the evidence that Vioxx (rofecoxib) and withdrawn drug, Bextra (valdecoxib), both so-called “Cox-2” inhibitors, should never have been approved by the FDA.    

Dr. Christianne Roumie of Vanderbilt University in Nashville, wanted to determine whether they, along with the non-steroidal anti-inflammatory drugs (NSAIDS) can also increase the risk of stroke. She and her colleagues studied six years of data on 336,000 Tennessee Medicaid enrollees. They ranged in age from 50 to 84 years. 

The drugs considered were the most common NSAIDS, including Vioxx, Celebrex, Bextra, ibuprofen, naproxen, indomethacin, and diclofenac.  Among participants more than 78,000 were current users of one of the seven. 

Also included were more than 16,000 patients taking other NSAIDS or NSAID combinations.  They were compared to a control group not taking drugs of more than 242,000 participants.

The risk of stroke for the Vioxx users was 28 percent higher compared to the control group.  The risk of stroke was 41 percent higher among Bextra users when compared to the control group.

Among those taking Celebrex or with other NSAIDs there was no significant increase in the risk of stroke. 

Dr. Roumie tells Reuters Health in an interview, that the withdrawl of Vioxx and Bextra from the market was appropriate and that they should not be reintroduced.

“Since all NSAIDs, including coxibs, can raise blood pressure and increase the risk of gastrointestinal bleeding, we believe that caution is warranted, especially with long-term use of these medicines."  

A study published in the New England Journal of Medicine last year by Oxford University researchers, showed that 16 of 23 cardiovascular events occurred in the Vioxx patients, half within 12 months of taking the drug.  Merck had argued that patients were not at additional risk from Vioxx unless they took the drug for 18 months.

"It would appear...that patients do not need to take rofecoxib (Vioxx) for 18 months to be at increased risk of a cardiovascular thrombotic event," the authors wrote. # 


Anonymous User
Posted by jo cronk
Friday, August 08, 2008 9:42 AM EST

My husband took Vioxx for almost 3 years. He and I were niaive regarding the effects of this drug. He ceased to take it on 30th Sept. 2004 when it was withdrawn from the market. He was undergoing treatment for ITA's and embollisms at the time. He died on 25th Oct. 2005, age 54 years. I wish I could hold Merck accountable for their ruthless, cruel actions but unfortunately I am British and live in the U.K. and consequently I have no recourse. My life ended on the same day as my husband's except that I continue to breathe whereas he couldn't, as he struggled to survive a massive heart attack and failed! These people MUST NOT be allowed to get away with their actions.

Anonymous User
Posted by Jane Akre
Friday, August 08, 2008 7:15 PM EST

Hello Jo-

Perhaps you have seen our next story where there is a movement in the UK to have folks there compensated as well. We are sorry for your loss. The woman quoted in the next story makes a good point, their lives in the UK are just as valuable as Americans! See:


Comments for this article are closed.

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact an Injury Board member

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address


RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes